Categories: News

Bigger and Better Together: PRECISIONeffect Acquires Pascāle, Expanding Capabilities with PR and Social Media Services

BOSTON, Aug. 3, 2021 /PRNewswire/ — PRECISIONeffect, the industry’s only healthcare advertising agency dedicated to changing the standard of care, today announced that it has acquired Pascāle, an international healthcare communications company specializing in public relations and social media. Pascāle has an almost two-decade history of launching full-scale, creative-fueled PR and social media campaigns to drive results for healthcare clients worldwide.

With this strategic acquisition, PRECISIONeffect enriches its offerings to clients with fully integrated PR and social media execution. These offerings can be engaged as standalones, partnerships, or as part of a robust, full-service capability for current and new clients.

“After collaborating with Pascāle on joint client work, we realized their approach to PR and social media mirrored how we approach our service offerings,” said Deborah Lotterman, chief creative officer at PRECISIONeffect. “When we dug deeper, we saw that our cultures, principles, and shared mission to develop market-changing work were also aligned. We are excited to join forces and work together with our clients to build brands that create unique and meaningful experiences.”

Driven by advances in technology and the industry, clients are increasingly seeking agencies that work across disciplines. Lotterman notes that about half of PRECISIONeffect’s clients have asked for deeper social media capabilities, including monitoring and response management, and nearly half of its clients have asked about PR services at one point or another. By integrating a deeper social bench and PR services from Pascāle, PRECISIONeffect can elevate the level of deliverables for clients and provide them with even more widely informed and actionable recommendations.

“Combining the weight and expertise of PRECISIONeffect with the PR and social reputation of Pascāle creates a powerhouse offering that will help our clients bring innovation to market and to patients with speed, relevance, and the right impact,” said Georgette Pascale, founder and CEO of Pascāle. “We’re thrilled to join PRECISIONeffect’s team of experienced, results-oriented individuals to work together to transform healthcare marketing communications and deliver targeted results with passion and authenticity.”

With this acquisition, PRECISIONeffect expands its employee count to 250 people and adds talent in communications, PR, and social media.

About PRECISIONeffect
PRECISIONeffect is the nation’s only healthcare advertising agency dedicated to working with companies seeking to change the standard of care. For more than four decades, the agency has developed creative market-changing and award-winning work for novel pharmaceuticals, biologics, devices, and diagnostics. The agency’s expertise in identifying and changing status quo–preserving behaviors has demonstrated success with physicians, patients, and caregivers across virtually every branch of medicine. The company has offices in Boston, Los Angeles, and London and is part of the Precision Value & Health team. For more information, visit www.precisioneffect.com or follow us on LinkedIn.

View original content to download multimedia:https://www.prnewswire.com/news-releases/bigger-and-better-together-precisioneffect-acquires-pascle-expanding-capabilities-with-pr-and-social-media-services-301347188.html

SOURCE PRECISIONeffect

Staff

Recent Posts

Interactive Strength Inc. (Nasdaq: TRNR) Issues Year-End Update, Looks Ahead to 2025

AUSTIN, TEXAS / ACCESSWIRE / December 23, 2024 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or…

9 minutes ago

Quest Diagnostics Upholds Strong Governance and Ethics With Robust Oversight, ESG Integration, and Comprehensive Risk Management

Originally published in Quest Diagnostics' 2023 Corporate Responsibility ReportNORTHAMPTON, MA / ACCESSWIRE / December 23,…

9 minutes ago

Phio Pharmaceuticals Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Marlborough, Massachusetts--(Newsfile Corp. - December 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage…

1 hour ago

ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay

WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…

3 hours ago

ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay

WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…

3 hours ago

Hallmark Adds Senior Executives to Enhance Customer Success and Strategic Partnerships

New leadership roles highlight Hallmark’s unique vendor-neutral approach to helping health systems build flexible, efficient,…

3 hours ago